Literature DB >> 26182162

Efficient palliative involved-field radiotherapy on highly progressive diffuse large B-cell primary gastric lymphoma with liver cirrhosis.

Junji Kohisa1, Kenya Kamimura2, Akito Iwanaga1, Kazuhiko Shioji1, Hirokazu Kawai1, Takeshi Suda1, Kenji Suzuki1, Junko Sakurada3, Makoto Naito3, Yutaka Aoyagi1.   

Abstract

We report the case of a 73-year-old woman having diffuse large B-cell primary gastric lymphoma with a cirrhotic liver caused by hepatitis C virus infection. She visited our hospital with symptoms of nausea and vomiting, which appeared to be caused by stenosis due to the tumor. Metastatic tumors were seen in the gastric and jugular lymph nodes. The clinical stage was IVB with a high risk of poor prognosis according to the international index. Because of poor hepatic reserve function, standard chemotherapy could not be administered. To maintain her quality of life, palliative involved-field radiotherapy was performed. The symptoms and tumor markers significantly improved, and computed tomography and endoscopy indicated the disappearance of the primary gastric tumor. Two months after radiotherapy and her return home, she died of pneumonia. Autopsy showed neither lymphoma cells nor stenosis of gastric lesion. The significant anti-tumor effect on primary tumor in our case suggests that the involved-field radiotherapy, although palliative, can be a therapeutic option for primary gastric lymphoma patients with various complications.

Entities:  

Keywords:  Diffuse large B-cell lymphoma; Gastric lymphoma; Hepatitis C virus; Liver cirrhosis; Radiotherapy

Year:  2012        PMID: 26182162     DOI: 10.1007/s12328-012-0292-7

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  33 in total

1.  Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Salvatore Guastafierro; Gilda Tonziello; Antonello Sica; Valentina Iodice; Caterina Sagnelli; Maria Giovanna Ferrara; Evangelista Sagnelli
Journal:  Dig Liver Dis       Date:  2011-08-31       Impact factor: 4.088

2.  Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma.

Authors:  W Fischbach; S Schramm; E Goebeler
Journal:  Z Gastroenterol       Date:  2011-04-07       Impact factor: 2.000

3.  Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma--results of the prospective German Multicenter Study GIT NHL 01/92.

Authors:  P Koch; F del Valle; W E Berdel; N A Willich; B Reers; W Hiddemann; B Grothaus-Pinke; G Reinartz; J Brockmann; A Temmesfeld; R Schmitz; C Rübe; A Probst; G Jaenke; H Bodenstein; A Junker; C Pott; J Schultze; A Heinecke; R Parwaresch; M Tiemann
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

4.  Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy.

Authors:  Jayant S Goda; Mary Gospodarowicz; Melania Pintilie; Woodrow Wells; David C Hodgson; Alexander Sun; Micheal Crump; Richard W Tsang
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

5.  Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH.

Authors:  Alexandra Nieters; Birgit Kallinowski; Paul Brennan; Melanie Ott; Marc Maynadié; Yolanda Benavente; Lenka Foretova; Pier Luigi Cocco; Anthony Staines; Martine Vornanen; Denise Whitby; Paolo Boffetta; Nikolaus Becker; Silvia De Sanjosé
Journal:  Gastroenterology       Date:  2006-09-20       Impact factor: 22.682

6.  Diffuse large B-cell primary gastric lymphoma treated successfully with the CD20 monoclonal antibody (rituximab): a case with severe liver dysfunction due to liver cirrhosis and hepatocellular carcinoma.

Authors:  Seiji Nakai; Tsutomu Masaki; Takamichi Shintani; Akihiro Deguchi; Yasuhiko Kimura; Takashi Himoto; Kazutaka Kurokohchi; Seishiro Watanabe; Shigeki Kuriyama
Journal:  Oncol Rep       Date:  2005-06       Impact factor: 3.906

7.  Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas.

Authors:  Luca Arcaini; Michele Merli; Francesco Passamonti; Raffaele Bruno; Ercole Brusamolino; Paolo Sacchi; Sara Rattotti; Ester Orlandi; Elisa Rumi; Virginia Ferretti; Silvia Rizzi; Erika Meli; Cristiana Pascutto; Marco Paulli; Mario Lazzarino
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

8.  Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.

Authors:  Silvia de Sanjose; Yolanda Benavente; Claire M Vajdic; Eric A Engels; Lindsay M Morton; Paige M Bracci; John J Spinelli; Tongzhang Zheng; Yawei Zhang; Silvia Franceschi; Renato Talamini; Elizabeth A Holly; Andrew E Grulich; James R Cerhan; Patricia Hartge; Wendy Cozen; Paolo Boffetta; Paul Brennan; Marc Maynadié; Pierluigi Cocco; Ramon Bosch; Lenka Foretova; Anthony Staines; Nikolaus Becker; Alexandra Nieters
Journal:  Clin Gastroenterol Hepatol       Date:  2008-04       Impact factor: 11.382

9.  Hepatitis C infection and risk of malignant lymphoma.

Authors:  Claudia Schöllkopf; Karin Ekström Smedby; Henrik Hjalgrim; Klaus Rostgaard; Inge Panum; Lasse Vinner; Ellen T Chang; Bengt Glimelius; Anna Porwit; Christer Sundström; Mads Hansen; Hans-Olov Adami; Mads Melbye
Journal:  Int J Cancer       Date:  2008-04-15       Impact factor: 7.396

10.  Early stage gastric lymphoma: is operation essential?

Authors:  Y Tanaka; T Takao; H Watanabe; T Kido; N Ogawa; K Iwase; S Sunada; K Sando; S Kawamoto; K Koto
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.